类风湿关节炎的联合治疗.pptVIP

Biosimilars: a SWOT analysis YOUNG RHEUMATOID ARTHRITIS PATIETNS ARE MORE LIKELY TO BE IN SDAI OR DAS28 REMISSION IN COMPARISON TO OLDER PATIETNS AFTER ONE YEAR OF TREATMETN WITH ADALIMUMAB OR ETANERCEPT ADHERENCE AND PERSISTENCE WITH TRIPLE NON-BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUG THERAPY AND ETANERCEPT-METHOTREXATE COMBINATION THERAPY IN US PATIETNS WITH RHEUMATOID ARTHRITIS EARLY RESPONSE TO ETANERCEPT-METHOTREXATE INDUCTION THERAPY PREDICTS SUSTAINED REMISSION WITH REDUCED-DOSE COMBINATION REGIMEN IN THE PRIZE STUDY THE IMPACT OF ETANERCEPT AND METHOTREXATE TREATMETN ON WORK PROD